Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction

M. C. C. M. Hulshof, H. W. M. van Laarhoven

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Abstract

Oesophageal cancer remains a malignancy with a poor prognosis. However, in the recent 10-15 years relevant progress has been made by the introduction of chemoradiotherapy (CRT) for tumours of the oesophagus or gastro-oesophageal junction. The addition of neo-adjuvant CRT to surgery has significantly improved survival and locoregional control, for both adenocarcinoma and squamous cell carcinoma. For irresectable or medically inoperable patients, definitive CRT has changed the treatment intent from palliative to curative. Definitive CRT is a good alternative for radical surgery in responding patients with squamous cell carcinoma and those running a high risk of surgical morbidity and mortality. For patients with an out-of-field solitary locoregional recurrence after primary curative treatment, definitive CRT can lead to long term survival
Original languageEnglish
Pages (from-to)551-563
JournalBest practice & research. Clinical gastroenterology
Volume30
Issue number4
DOIs
Publication statusPublished - 2016

Cite this